Interleukin-1α and -1β promoter polymorphisms in Taiwanese patients with dementia

Hsiu Kuan Wang, Wen Chuin Hsu, Hon Chung Fung, Jun Cheng Lin, Hai Pei Hsu, Yih Ru Wu, Yuying Hsu, Fen Ju Hu, Guey Jen Lee-Chen, Chiung Mei Chen

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background: Inflammatory events may contribute to the pathogenesis of dementia and interleukin-1 (IL-1) may exert both neurotoxic and neuroprotective effects. We investigated whether IL-1α -889 C/T and IL-1β -511 C/T promoter polymorphisms are associated with the risk of Alzheimer's disease (AD) and vascular dementia (VaD). Methods: AD patients (n = 219) and VaD patients (n = 82), who fulfilled the criteria of the NINCDS-ADRDA and NINDS-AIREN, and ethnic-matched and nondemented controls (n = 209) were analyzed by means of genotype association method. Results: No significant difference in the genotype distribution of the analyzed single nucleotide polymorphisms was found between AD or VaD cases and controls. However, the frequency of the IL-1α -889 CT genotype was notably lower in VaD patients aged over 70 years than the age-matched controls (9.1 vs. 22.9%, p = 0.036) andtheIL-1α -889 CT genotype demonstrated a trend toward decrease in risk of developing VaD (odds ratio: 0.34; 95% confidence interval: 0.12-0.83, p = 0.026). Multivariate analysis revealed that the IL-1β -511T-carrying genotype slightly strengthens the negative association of the IL-1α -889 CT genotype with VaD (odds ratio: 0.26; 95% confidence interval: 0.08-0.79, p = 0.024). Conclusion: Our data suggest a protective role of the IL-1α -889 CT genotype in VaD susceptibility among Taiwanese aged over 70 years.

Original languageEnglish
Pages (from-to)104-110
Number of pages7
JournalDementia and Geriatric Cognitive Disorders
Volume24
Issue number2
DOIs
Publication statusPublished - 2007 Jul 1

Fingerprint

Vascular Dementia
Interleukin-1
Dementia
Genotype
Alzheimer Disease
Odds Ratio
National Institute of Neurological Disorders and Stroke
Confidence Intervals
Neuroprotective Agents
Single Nucleotide Polymorphism
Multivariate Analysis

Keywords

  • Alzheimer's disease
  • Interleukin-1
  • Promoter single nucleotide polymorphism
  • Vascular dementia

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Cognitive Neuroscience
  • Psychiatry and Mental health

Cite this

Wang, H. K., Hsu, W. C., Fung, H. C., Lin, J. C., Hsu, H. P., Wu, Y. R., ... Chen, C. M. (2007). Interleukin-1α and -1β promoter polymorphisms in Taiwanese patients with dementia. Dementia and Geriatric Cognitive Disorders, 24(2), 104-110. https://doi.org/10.1159/000104829

Interleukin-1α and -1β promoter polymorphisms in Taiwanese patients with dementia. / Wang, Hsiu Kuan; Hsu, Wen Chuin; Fung, Hon Chung; Lin, Jun Cheng; Hsu, Hai Pei; Wu, Yih Ru; Hsu, Yuying; Hu, Fen Ju; Lee-Chen, Guey Jen; Chen, Chiung Mei.

In: Dementia and Geriatric Cognitive Disorders, Vol. 24, No. 2, 01.07.2007, p. 104-110.

Research output: Contribution to journalArticle

Wang, Hsiu Kuan ; Hsu, Wen Chuin ; Fung, Hon Chung ; Lin, Jun Cheng ; Hsu, Hai Pei ; Wu, Yih Ru ; Hsu, Yuying ; Hu, Fen Ju ; Lee-Chen, Guey Jen ; Chen, Chiung Mei. / Interleukin-1α and -1β promoter polymorphisms in Taiwanese patients with dementia. In: Dementia and Geriatric Cognitive Disorders. 2007 ; Vol. 24, No. 2. pp. 104-110.
@article{22b584314c5f43f7b913c70521e62f24,
title = "Interleukin-1α and -1β promoter polymorphisms in Taiwanese patients with dementia",
abstract = "Background: Inflammatory events may contribute to the pathogenesis of dementia and interleukin-1 (IL-1) may exert both neurotoxic and neuroprotective effects. We investigated whether IL-1α -889 C/T and IL-1β -511 C/T promoter polymorphisms are associated with the risk of Alzheimer's disease (AD) and vascular dementia (VaD). Methods: AD patients (n = 219) and VaD patients (n = 82), who fulfilled the criteria of the NINCDS-ADRDA and NINDS-AIREN, and ethnic-matched and nondemented controls (n = 209) were analyzed by means of genotype association method. Results: No significant difference in the genotype distribution of the analyzed single nucleotide polymorphisms was found between AD or VaD cases and controls. However, the frequency of the IL-1α -889 CT genotype was notably lower in VaD patients aged over 70 years than the age-matched controls (9.1 vs. 22.9{\%}, p = 0.036) andtheIL-1α -889 CT genotype demonstrated a trend toward decrease in risk of developing VaD (odds ratio: 0.34; 95{\%} confidence interval: 0.12-0.83, p = 0.026). Multivariate analysis revealed that the IL-1β -511T-carrying genotype slightly strengthens the negative association of the IL-1α -889 CT genotype with VaD (odds ratio: 0.26; 95{\%} confidence interval: 0.08-0.79, p = 0.024). Conclusion: Our data suggest a protective role of the IL-1α -889 CT genotype in VaD susceptibility among Taiwanese aged over 70 years.",
keywords = "Alzheimer's disease, Interleukin-1, Promoter single nucleotide polymorphism, Vascular dementia",
author = "Wang, {Hsiu Kuan} and Hsu, {Wen Chuin} and Fung, {Hon Chung} and Lin, {Jun Cheng} and Hsu, {Hai Pei} and Wu, {Yih Ru} and Yuying Hsu and Hu, {Fen Ju} and Lee-Chen, {Guey Jen} and Chen, {Chiung Mei}",
year = "2007",
month = "7",
day = "1",
doi = "10.1159/000104829",
language = "English",
volume = "24",
pages = "104--110",
journal = "Dementia and Geriatric Cognitive Disorders",
issn = "1420-8008",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Interleukin-1α and -1β promoter polymorphisms in Taiwanese patients with dementia

AU - Wang, Hsiu Kuan

AU - Hsu, Wen Chuin

AU - Fung, Hon Chung

AU - Lin, Jun Cheng

AU - Hsu, Hai Pei

AU - Wu, Yih Ru

AU - Hsu, Yuying

AU - Hu, Fen Ju

AU - Lee-Chen, Guey Jen

AU - Chen, Chiung Mei

PY - 2007/7/1

Y1 - 2007/7/1

N2 - Background: Inflammatory events may contribute to the pathogenesis of dementia and interleukin-1 (IL-1) may exert both neurotoxic and neuroprotective effects. We investigated whether IL-1α -889 C/T and IL-1β -511 C/T promoter polymorphisms are associated with the risk of Alzheimer's disease (AD) and vascular dementia (VaD). Methods: AD patients (n = 219) and VaD patients (n = 82), who fulfilled the criteria of the NINCDS-ADRDA and NINDS-AIREN, and ethnic-matched and nondemented controls (n = 209) were analyzed by means of genotype association method. Results: No significant difference in the genotype distribution of the analyzed single nucleotide polymorphisms was found between AD or VaD cases and controls. However, the frequency of the IL-1α -889 CT genotype was notably lower in VaD patients aged over 70 years than the age-matched controls (9.1 vs. 22.9%, p = 0.036) andtheIL-1α -889 CT genotype demonstrated a trend toward decrease in risk of developing VaD (odds ratio: 0.34; 95% confidence interval: 0.12-0.83, p = 0.026). Multivariate analysis revealed that the IL-1β -511T-carrying genotype slightly strengthens the negative association of the IL-1α -889 CT genotype with VaD (odds ratio: 0.26; 95% confidence interval: 0.08-0.79, p = 0.024). Conclusion: Our data suggest a protective role of the IL-1α -889 CT genotype in VaD susceptibility among Taiwanese aged over 70 years.

AB - Background: Inflammatory events may contribute to the pathogenesis of dementia and interleukin-1 (IL-1) may exert both neurotoxic and neuroprotective effects. We investigated whether IL-1α -889 C/T and IL-1β -511 C/T promoter polymorphisms are associated with the risk of Alzheimer's disease (AD) and vascular dementia (VaD). Methods: AD patients (n = 219) and VaD patients (n = 82), who fulfilled the criteria of the NINCDS-ADRDA and NINDS-AIREN, and ethnic-matched and nondemented controls (n = 209) were analyzed by means of genotype association method. Results: No significant difference in the genotype distribution of the analyzed single nucleotide polymorphisms was found between AD or VaD cases and controls. However, the frequency of the IL-1α -889 CT genotype was notably lower in VaD patients aged over 70 years than the age-matched controls (9.1 vs. 22.9%, p = 0.036) andtheIL-1α -889 CT genotype demonstrated a trend toward decrease in risk of developing VaD (odds ratio: 0.34; 95% confidence interval: 0.12-0.83, p = 0.026). Multivariate analysis revealed that the IL-1β -511T-carrying genotype slightly strengthens the negative association of the IL-1α -889 CT genotype with VaD (odds ratio: 0.26; 95% confidence interval: 0.08-0.79, p = 0.024). Conclusion: Our data suggest a protective role of the IL-1α -889 CT genotype in VaD susceptibility among Taiwanese aged over 70 years.

KW - Alzheimer's disease

KW - Interleukin-1

KW - Promoter single nucleotide polymorphism

KW - Vascular dementia

UR - http://www.scopus.com/inward/record.url?scp=34447626071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447626071&partnerID=8YFLogxK

U2 - 10.1159/000104829

DO - 10.1159/000104829

M3 - Article

C2 - 17622713

AN - SCOPUS:34447626071

VL - 24

SP - 104

EP - 110

JO - Dementia and Geriatric Cognitive Disorders

JF - Dementia and Geriatric Cognitive Disorders

SN - 1420-8008

IS - 2

ER -